Literature DB >> 12006913

Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study.

Lilja S Jónsdóttir1, Nikulás Sigfússon, Vilmundur Gudnason, Helgi Sigvaldason, Gudmundur Thorgeirsson.   

Abstract

BACKGROUND: Studies on coronary risk factors in men and women are mainly based on mortality data and few compare results of both sexes with consistent study design and diagnostic criteria. This study assesses the major risk factors for coronary events in men and women from the Reykjavik Study.
DESIGN: Within a prospective, population-based cohort study individuals without history of myocardial infarction were identified and the relative risk of baseline variables was assessed in relation to verified myocardial infarction or coronary death during follow-up.
METHODS: Of the 9681 women and 8888 men who attended risk assessment from 1967-1991, with follow-up period of up to 28 years, 706 women and 1700 men suffered a non-fatal myocardial infarction or coronary death.
RESULTS: Serum cholesterol was a significant risk factor for both sexes, with hazard ratios (HR) decreasing with age. Systolic blood pressure was a stronger risk factor for women as was ECG-confirmed left ventricular hypertrophy (women HR 2.89, 95% confidence interval [CI] 1.67-5.01; men HR 1.11 [CI 0.86-1.43]). Fasting blood glucose > or =6.7 mmol/L identified significantly higher risk for women (HR 2.65) than men (HR 2.08) as did self-reported diabetes. Triglyceride risk was significantly higher for women and decreased significantly with age. Smoking increased risk two- to five-fold, increasing with dose, for women, which was significantly higher than the doubling in risk for men.
CONCLUSIONS: This large study of the major risk factors compared between the sexes demonstrates similar relative risk of myocardial infarction associated with cholesterol for both sexes, however, the relative risk is higher in women for many other risk factors such as smoking, diabetes, elevated triglycerides and left ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006913

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  48 in total

1.  Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.

Authors:  Rebeccah A McKibben; Mahmoud Al Rifai; Lena M Mathews; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-12-29

2.  Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs.

Authors:  C J Hawkey; G M Hawkey; S Everitt; M M Skelly; W A Stack; D Gray
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

3.  Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events.

Authors:  Sanne A E Peters; Rachel R Huxley; Mark Woodward
Journal:  Diabetologia       Date:  2014-05-25       Impact factor: 10.122

Review 4.  Fibrate therapy in the management of diabetic dyslipidemia: there is no ACCORD to be found.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2010-09       Impact factor: 5.113

5.  IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes.

Authors:  S Rodriguez; G Eiriksdottir; T R Gaunt; T B Harris; L J Launer; V Gudnason; I N M Day
Journal:  Growth Horm IGF Res       Date:  2010-08       Impact factor: 2.372

6.  Cardiovascular Disease in Women Across the Lifespan: The Importance of Sleep.

Authors:  Stacie L Daugherty; Jason R Carter; Ghada Bourjeily
Journal:  J Womens Health (Larchmt)       Date:  2020-02-25       Impact factor: 2.681

Review 7.  Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

Authors:  Nadeem Sarwar; Thor Aspelund; Gudny Eiriksdottir; Reeta Gobin; Sreenivasa Rao Kondapally Seshasai; Nita G Forouhi; Gunnar Sigurdsson; John Danesh; Vilmundur Gudnason
Journal:  PLoS Med       Date:  2010-05-25       Impact factor: 11.069

8.  Hypothyroidism and the risk of lower extremity arterial disease.

Authors:  Michael A Mazzeffi; Hung-Mo Lin; Brigid C Flynn; Thomas L O'Connell; David E DeLaet
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

9.  Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study.

Authors:  Larus S Gudmundsson; Ann I Scher; Thor Aspelund; Jon H Eliasson; Magnus Johannsson; Gudmundur Thorgeirsson; Lenore Launer; Vilmundur Gudnason
Journal:  BMJ       Date:  2010-08-24

10.  Midlife metabolic factors and prostate cancer risk in later life.

Authors:  Barbra A Dickerman; Johanna E Torfadottir; Unnur A Valdimarsdottir; Kathryn M Wilson; Laufey Steingrimsdottir; Thor Aspelund; Julie L Batista; Katja Fall; Edward Giovannucci; Lara G Sigurdardottir; Laufey Tryggvadottir; Vilmundur Gudnason; Sarah C Markt; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2017-11-16       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.